4.7 Article

Fabrication and characterization of a triple functionalization of graphene oxide with Fe3O4, folic acid and doxorubicin as dual-targeted drug nanocarrier

Journal

COLLOIDS AND SURFACES B-BIOINTERFACES
Volume 106, Issue -, Pages 60-65

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.colsurfb.2013.01.032

Keywords

Graphene oxide; Fe3O4 nanoparticles; Folic acid; Chitosan; Dual-targeted drug nanocarrier

Funding

  1. National Natural Science Foundation of China [20975056, 21275082, 81102411]
  2. Natural Science Foundation of Shandong [ZR2011BZ004, ZR2011BQ005]
  3. JSPS Japan [21111140014]
  4. NSFC China [21111140014]
  5. State Key Laboratory of Analytical Chemistry for Life Science [SKLACLS1110]
  6. National Key Basic Research Development Program of China (973 special preliminary study plan, grant) [2012CB722705]

Ask authors/readers for more resources

A novel triple functionalized drug delivery system was synthesized by encapsulation of superparamagnetic graphene oxide (GO) and doxorubicin (DOX) with folic acid (FA) conjugated chitosan (CHI). The carrier exhibited a high loading efficiency (0.98 mg/mg), a high saturation magnetization (10.5 emu/g) and a prolonged release rate. A real-time monitoring method on the drug release from graphene oxide (GO) was reported using DOX as the model drug. The release mechanism of DOX at different pH was investigated via monitoring the time dependency of the accumulative drug release. Results show that the drug release of DOX was pH sensitive as observed at pH 5.3 and pH 7.4 PBS solutions, the lower pH values lead to weaker hydrogen bonds and degradation of CHI, and thus result in a higher release rate of DOX. Especially, this system could be applied as a dual-targeted drug nanocarrier by combined biological (active) and magnetical (passive) targeting capabilities. Our research suggests that a novel triple functionalized, pH-responsive nanocarrier for anticancer drug has been synthesized. (C) 2013 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available